INTELLIA THERAPEUTICS INC (NTLA) Stock Earnings & Estimates
USA - NASDAQ:NTLA - US45826J1051 - Common Stock
17.27 USD
+0.35 (+2.07%)
17.19 USD
-0.08 (-0.46%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 52.12M 57.70% | 36.275M -30.40% | 57.877M 59.55% | 63.027M 8.90% | 53.559M -15.02% | 69.229M 29.26% | 910.13M 1,214.67% | 1.876B 106.12% | 2.771B 47.71% | 1.417B -48.86% | 1.958B 38.18% | |
| EBITDA YoY % growth | -450.59M -72.67% | -506.315M -12.37% | -523.978M -3.49% | -455.964M 12.98% | -430.997M 5.48% | -416.5M 3.36% | -380.46M 8.65% | -63.24M 83.38% | 445.74M 804.84% | 857.82M 92.45% | 1.191B 38.84% | |
| EBIT YoY % growth | -458.16M -71.05% | -515.291M -12.47% | -534.263M -3.68% | -461.652M 13.59% | -461.349M 0.07% | -449.601M 2.55% | 66.008M 114.68% | 581.51M 780.97% | 1.16B 99.48% | 377.31M -67.47% | 637.33M 68.91% | |
| Operating Margin | -879.05% | -1,420.51% | -923.10% | -732.47% | -861.38% | -649.44% | 7.25% | 31.00% | 41.86% | 26.63% | 32.55% | |
| EPS YoY % growth | -6.18 -64.36% | -5.41 12.46% | -5.25 2.96% | -4.19 20.11% | -4.03 4.03% | -3.70 8.10% | 1.85 150.00% | 7.55 308.00% | 13.69 81.44% | 4.51 -67.05% | 6.67 47.94% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.01 24.34% | -1.01 20.82% | -1.08 2.16% | -1.11 -13.01% | -1.14 -11.98% | -1.06 -5.87% | 0.01 101.30% | 0.02 101.45% | 0.04 103.55% | 0.05 104.53% |
| Revenue Q2Q % growth | 15.164M 66.44% | 20.533M 59.49% | 12.009M -27.77% | 10.592M -25.64% | 10.084M -33.50% | 10.094M -50.84% | 217.66M 1,712.47% | 226.8M 2,041.24% | 233.02M 2,210.79% | 240.97M 2,287.26% |
| EBITDA Q2Q % growth | -106.08M 22.60% | -103.02M 18.34% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -110.444M 23.71% | -108.045M 20.82% | -125.292M -3.71% | -128.255M -16.60% | -127.9M -15.81% | -121.419M -12.38% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.98 35.53% | -1.04 | 0.06 | 5.61% |
| Q1 2025 Q2Q % growth | -1.10 1.79% | -1.31 | 0.21 | 15.91% |
| Q4 2024 Q2Q % growth | -1.27 13.01% | -1.36 | 0.09 | 6.34% |
| Q3 2024 Q2Q % growth | -1.34 2.90% | -1.41 | 0.07 | 5.12% |
| Q2 2024 Q2Q % growth | -1.52 -8.57% | -1.26 | -0.26 | -20.94% |
| Q1 2024 Q2Q % growth | -1.12 4.27% | -1.41 | 0.29 | 20.41% |
| Q4 2023 Q2Q % growth | -1.46 -4.29% | -1.48 | 0.02 | 1.23% |
| Q3 2023 Q2Q % growth | -1.38 7.38% | -1.53 | 0.15 | 9.73% |
| Q2 2023 Q2Q % growth | -1.40 -5.26% | -1.35 | -0.05 | -3.91% |
| Q1 2023 Q2Q % growth | -1.17 40.31% | -1.43 | 0.26 | 18.08% |
| Q4 2022 Q2Q % growth | -1.40 -28.44% | -1.42 | 0.02 | 1.45% |
| Q3 2022 Q2Q % growth | -1.49 -53.61% | -1.31 | -0.18 | -13.96% |
| Q2 2022 Q2Q % growth | -1.33 -31.68% | -1.33 | 0.00 | 0.17% |
| Q1 2022 Q2Q % growth | -1.96 -184.06% | -1.13 | -0.83 | -73.90% |
| Q4 2021 Q2Q % growth | -1.09 -57.97% | -0.96 | -0.13 | -13.14% |
| Q3 2021 Q2Q % growth | -0.97 -106.38% | -0.86 | -0.11 | -12.71% |
| Q2 2021 Q2Q % growth | -1.01 -65.57% | -0.65 | -0.36 | -56.35% |
| Q1 2021 Q2Q % growth | -0.69 -9.52% | -0.67 | -0.02 | -2.83% |
| Q4 2020 Q2Q % growth | -0.69 -21.05% | -0.61 | -0.08 | -12.32% |
| Q3 2020 Q2Q % growth | -0.47 4.08% | -0.60 | 0.13 | 21.98% |
| Q2 2020 Q2Q % growth | -0.61 -8.93% | -0.70 | 0.09 | 13.41% |
| Q1 2020 Q2Q % growth | -0.63 -28.57% | -0.43 | -0.20 | -45.52% |
| Q4 2019 Q2Q % growth | -0.57 | -0.57 | 0.00 | 0.65% |
| Q3 2019 Q2Q % growth | -0.49 | -0.63 | 0.14 | 22.37% |
| Q2 2019 Q2Q % growth | -0.56 | -0.61 | 0.05 | 8.91% |
| Q1 2019 Q2Q % growth | -0.49 | -0.60 | 0.11 | 18.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 14.245M 104.76% | 12.402M | 1.843M | 14.86% |
| Q1 2025 Q2Q % growth | 16.627M -42.54% | 12.111M | 4.516M | 37.29% |
| Q4 2024 Q2Q % growth | 12.874M 771.57% | 8.703M | 4.171M | 47.93% |
| Q3 2024 Q2Q % growth | 9.111M -24.02% | 8.013M | 1.098M | 13.70% |
| Q2 2024 Q2Q % growth | 6.957M -48.82% | 19.545M | -12.588M | -64.41% |
| Q1 2024 Q2Q % growth | 28.935M 129.53% | 11.734M | 17.201M | 146.59% |
| Q4 2023 Q2Q % growth | -1.917M -114.13% | 13.082M | -14.999M | -114.65% |
| Q3 2023 Q2Q % growth | 11.992M -9.63% | 12.697M | -705K | -5.55% |
| Q2 2023 Q2Q % growth | 13.594M -3.11% | 12.319M | 1.275M | 10.35% |
| Q1 2023 Q2Q % growth | 12.606M 12.05% | 12.063M | 543K | 4.50% |
| Q4 2022 Q2Q % growth | 13.57M 5.60% | 11.558M | 2.012M | 17.41% |
| Q3 2022 Q2Q % growth | 13.27M 84.31% | 11.569M | 1.701M | 14.70% |
| Q2 2022 Q2Q % growth | 14.03M 114.20% | 9.602M | 4.428M | 46.12% |
| Q1 2022 Q2Q % growth | 11.25M 74.42% | 8.715M | 2.535M | 29.09% |
| Q4 2021 Q2Q % growth | 12.85M 94.70% | 8.426M | 4.424M | 52.50% |
| Q3 2021 Q2Q % growth | 7.2M -67.60% | 8.837M | -1.637M | -18.52% |
| Q2 2021 Q2Q % growth | 6.55M -59.72% | 12.128M | -5.578M | -45.99% |
| Q1 2021 Q2Q % growth | 6.45M -50.08% | 10.055M | -3.605M | -35.85% |
| Q4 2020 Q2Q % growth | 6.6M -39.67% | 14.377M | -7.777M | -54.09% |
| Q3 2020 Q2Q % growth | 22.22M 109.23% | 15.896M | 6.324M | 39.78% |
| Q2 2020 Q2Q % growth | 16.26M 46.22% | 8.716M | 7.544M | 86.55% |
| Q1 2020 Q2Q % growth | 12.92M 23.87% | 19.782M | -6.862M | -34.69% |
| Q4 2019 Q2Q % growth | 10.94M | 10.137M | 803K | 7.92% |
| Q3 2019 Q2Q % growth | 10.62M | 9.615M | 1.005M | 10.45% |
| Q2 2019 Q2Q % growth | 11.12M | 7.257M | 3.863M | 53.23% |
| Q1 2019 Q2Q % growth | 10.43M | 7.757M | 2.673M | 34.46% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.82% | 0.4% | -0.6% | 2.26% |
| Revenue | 4.01% | 19.84% | 0.53% | 9.25% |